Early PET/CT scan is more effective than RECIST in predicting outcome of patients with liver metastases from colorectal cancer treated with preoperative chemotherapy plus bevacizumab.
about
Timing and extent of response in colorectal cancer: critical review of current data and implication for future trialsPositron Emission Tomography for the Response Evaluation following Treatment with Chemotherapy in Patients Affected by Colorectal Liver Metastases: A Selected ReviewPrognostic significance of (18)FDG PET/CT in colorectal cancer patients with liver metastases: a meta-analysisPrognostic and predictive response factors in colorectal cancer patients: between hope and reality.Diagnostic accuracy of diffusion-weighted magnetic resonance imaging versus positron emission tomography/computed tomography for early response assessment of liver metastases to Y90-radioembolization.The Prognostic Significance of Metabolic Response Heterogeneity in Metastatic Colorectal CancerA randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme).Early 18F-FDG PET/CT Evaluation Shows Heterogeneous Metabolic Responses to Anti-EGFR Therapy in Patients with Metastatic Colorectal Cancer.Neoadjuvant and conversion treatment of patients with colorectal liver metastasis: the potential role of bevacizumab and other antiangiogenic agentsIs early response by (18)F-2-fluoro-2-deoxy-D-glucose positron emission tomography-computed tomography a predictor of long-term outcome in patients with metastatic colorectal cancer?Nonsurgical giant cell tumour of the tendon sheath or of the diffuse type: are MRI or 18F-FDG PET/CT able to provide an accurate prediction of long-term outcome?Prognostic factors for survival with bevacizumab-based therapy in colorectal cancer patients: a systematic review and pooled analysis of 11,585 patients.Colorectal cancer with Synchronous liver-limited Metastases: the protocol of an Inception Cohort study (CoSMIC).Surrogate Imaging Biomarkers of Response of Colorectal Liver Metastases After Salvage Radioembolization Using 90Y-Loaded Resin Microspheres.Performance of tumor growth kinetics as an imaging biomarker for response assessment in colorectal liver metastases: correlation with FDG PET.Tumor histopathology predicts outcomes after resection of colorectal cancer liver metastases treated with and without pre-operative chemotherapy.Identifying an early indicator of drug efficacy in patients with metastatic colorectal cancer-a prospective evaluation of circulating tumor cells, 18F-fluorodeoxyglucose positron-emission tomography and the RECIST criteria.Prospective evaluation of plasma Epstein-Barr virus DNA clearance and fluorodeoxyglucose positron emission scan in assessing early response to chemotherapy in patients with advanced or recurrent nasopharyngeal carcinoma.Surgical Treatment following Chemo-Targeted Therapy with Bevacizumab for Lung Metastasis from Colorectal Carcinoma: Analysis of Safety and Histological Therapeutic Effects in Patients Treated at a Single Institution.Late gadolinium enhancement of colorectal liver metastases post-chemotherapy is associated with tumour fibrosis and overall survival post-hepatectomy
P2860
Q26797292-29145CCF-3E21-491F-9B9E-2EB75FA1F52EQ27009240-57D9D51D-4969-4D34-A05C-9125A191C955Q28081159-306DB360-F8DB-4C87-A66C-1BBBC8F8862EQ34467133-EF52140D-7920-4C6A-A04D-ACFDCD822E02Q35570801-98DDAA96-53BC-4D9A-8817-B3EF4F2455E8Q35793080-675108C3-F67B-4E01-91B6-D55A783B0A42Q35917810-22A8E547-141B-4D2A-965A-24EE4BC5A697Q36022493-C0350045-E2E3-4D15-8450-D1B9F3124418Q36343047-C053E6CE-9664-4E19-8F82-848383D45BDDQ36936979-F475CA47-CC08-4797-BC1F-F6EEC79C6398Q38264850-0384527B-4CFF-42F2-9641-9578AE97F021Q38312076-12F311EE-5213-4D83-A5A1-27ED576D733CQ38732104-2B20817A-8AAA-4DF4-BE9C-62B53E885D89Q38888162-B5F51736-AE92-4953-B1B3-4CAAEBDE1404Q40557514-00A59571-B127-4AF0-B00A-C79F0778F9B0Q45032127-09BAEF7E-91AC-42AC-BD3B-3A8782E5AC18Q47925636-C7413CCA-0876-402F-854B-A96A2057CEAFQ52647899-18BEDD25-A81A-49CC-AA2A-6A656872581EQ55346189-A3CCD033-4F3A-4FF4-A4A8-C2746945519BQ56524446-0D586920-D5B8-46EE-9B7F-C5210F7BF3F8
P2860
Early PET/CT scan is more effective than RECIST in predicting outcome of patients with liver metastases from colorectal cancer treated with preoperative chemotherapy plus bevacizumab.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Early PET/CT scan is more effe ...... chemotherapy plus bevacizumab.
@en
Early PET/CT scan is more effe ...... chemotherapy plus bevacizumab.
@nl
type
label
Early PET/CT scan is more effe ...... chemotherapy plus bevacizumab.
@en
Early PET/CT scan is more effe ...... chemotherapy plus bevacizumab.
@nl
prefLabel
Early PET/CT scan is more effe ...... chemotherapy plus bevacizumab.
@en
Early PET/CT scan is more effe ...... chemotherapy plus bevacizumab.
@nl
P2093
P50
P921
P1476
Early PET/CT scan is more effe ...... chemotherapy plus bevacizumab
@en
P2093
Alessandro Ottaiano
Cecilia Arrichiello
Ciro Gallo
Corradina Caracò
Elisabetta de Lutio di Castelguidone
Francesco Perrone
Luigi Aloj
Maria Carmela Piccirillo
Pasqualina Giordano
Rosario Vincenzo Iaffaioli
P304
P356
10.2967/JNUMED.113.119909
P407
P577
2013-10-17T00:00:00Z